Diagnostic and prognostic markers for human prostate cancer

The Prostate
X GaoK V Honn

Abstract

The incidence and mortality of prostate cancer are increasing at alarming rates, partially due to an aging population. Early detection of prostate cancer, using clinically sensitive procedures and/or tumor markers (e.g., prostate-specific antigen [PSA]), is of prime importance. However, the choice of therapeutic interventions for prostate cancer at the time of diagnosis is largely dependent on clinical and pathologic staging and prediction of the degree of aggressiveness of the disease. Clinically applicable prognostic markers are urgently needed to assist in the selection of optimal therapy. Literature review of the potential diagnostic and prognostic markers for human prostate cancer. Well-established tissue prognostic indicators, including histologic grade, margin positivity, pathologic stage, intraglandular tumor extent, and DNA ploidy, are not reviewed in this paper. Recently, a number of novel markers have been identified. In this paper, we begin with a discussion of a number of well-established as well as investigational diagnostic markers and then focus on evaluation of prognostic markers. Diagnostic markers that have prognostic value and investigational prognostic markers are also discussed. Currently, only PSA is util...Continue Reading

References

Dec 22, 1977·The New England Journal of Medicine·A G FotiR R Malvaez
Mar 1, 1992·Human Pathology·P A di Sant'Agnese
Jan 1, 1992·The Journal of Urology·H A FrazierD F Paulson
Mar 1, 1992·The Journal of Urology·M K BrawerP H Lange
Mar 1, 1992·The Journal of Urology·F LabrieJ Emond
Apr 22, 1992·JAMA : the Journal of the American Medical Association·H B CarterP C Walsh
May 15, 1992·Biochemical and Biophysical Research Communications·F S Sharief, S S Li
Aug 1, 1992·The American Journal of Surgical Pathology·C M McLachlin, J R Srigley
Jan 1, 1992·The Prostate. Supplement·L J Denis
Mar 22, 1991·International Journal of Cancer. Journal International Du Cancer·G L WrightP F Schellhammer
Apr 25, 1991·The New England Journal of Medicine·W J CatalonaG L Andriole
Feb 1, 1992·The Journal of Urology·M A GhoneimN G Kock
Jul 1, 1991·Archives of Andrology·M KamadaS S Koide
Apr 17, 1991·Journal of the National Cancer Institute·C R BaquetP Greenwald
Oct 1, 1990·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·J P Brozna
Jul 15, 1990·International Journal of Cancer. Journal International Du Cancer·G L WrightM Morningstar
Oct 1, 1990·British Journal of Urology·R J CohenD Afrika
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·K W WattR Loor
Apr 1, 1987·The Journal of Urology·P GuinanP Ray
Oct 8, 1987·The New England Journal of Medicine·T A StameyE Redwine
Feb 28, 1989·Biochemical and Biophysical Research Communications·P H RiegmanJ Trapman
Apr 14, 1989·Biochemical and Biophysical Research Communications·F S ShariefS S Li
Jan 1, 1981·The Prostate·M C WangT M Chu
Jan 1, 1981·The Prostate·L T YamC Y Li

❮ Previous
Next ❯

Citations

Jun 25, 2005·Journal of Clinical Pathology·C HughesJ O'Leary
Mar 3, 2007·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Cyril BarinkaJacek Lubkowski
Dec 13, 2005·Cell Death and Differentiation·G M PierantoniA Fusco
Feb 4, 2010·Expert Review of Proteomics·Samantha E T LarkinPaul A Townsend
Feb 22, 2011·Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society·Anant MadabhushiGeorge Lee
May 19, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yoshiyuki Hattori, Yoshie Maitani
Aug 1, 2008·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·Nikolai V Slavine, Peter P Antich
May 7, 2002·The Journal of Urology·X S OuyangY C Wong
May 22, 2003·Progress in Histochemistry and Cytochemistry·Luis M MontuengaAna C Villaro
Oct 10, 2001·The Urologic Clinics of North America·M R Feneley, A W Partin
Aug 14, 1999·International Journal of Cancer. Journal International Du Cancer·N L van HalR H Brakenhoff
Oct 6, 1998·Critical Reviews in Clinical Laboratory Sciences·H G RittenhouseA W Partin
Sep 15, 2001·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·M J SoT J Sebo
Mar 13, 1999·International Journal of Cancer. Journal International Du Cancer·F DumasS Loric
Mar 25, 2006·Future Oncology·Sabarni K Chatterjee, Bruce R Zetter
Jun 15, 1999·BJU International·J P Van Brussel, G H Mickisch
Mar 18, 2004·The Journal of Steroid Biochemistry and Molecular Biology·Derek MorrowStephen Safe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Andrew J StephensonMichael W Kattan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Andrew J StephensonPeter T Scardino
© 2021 Meta ULC. All rights reserved